基于mRNA和DNA的疫苗用于生殖尿道癌症:个性化免疫疗法的新前沿
Jasmine Vohra1,2, Gabriela Rodrigues Barbosa2,3, Leonardo O Reis2,3,4
1Department of Biomedical Engineering, Vidyalankar Institute of Technology, Mumbai 400037, India.
Vaccines
|September 27, 2025
概括
个性化mRNA和DNA疫苗在治疗生殖尿道癌症方面表现有前途. 这些先进的免疫疗法旨在通过向个体瘤形状来产生持久的抗瘤反应.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 疫苗开发 疫苗开发
背景情况:
- 生殖尿道 (GU) 癌症是全球健康面临的重大挑战.
- 对于GU癌症的传统治疗有局限性,包括耐药性和复发性.
- 癌症免疫疗法,特别是个性化疫苗,提供了新的治疗途径.
研究的目的:
- 审查针对GU癌症的mRNA和DNA疫苗的现状.
- 讨论临床前发现和正在进行的临床试验.
- 突出针对GU恶性瘤的疫苗开发的挑战和未来方向.
主要方法:
- 在GU癌症中对mRNA和DNA疫苗的当前文献的综述.
- 分析临床前数据和正在进行的临床试验结果.
- 讨论交付技术和组合策略.
主要成果:
- mRNA疫苗是快速的,可扩展的,在癌症试验中显示出早期的希望.
- DNA疫苗是稳定的,可以诱导强大的细胞毒性T细胞反应.
- 个性化疫苗利用新抗原识别和下一代测序.
结论:
- mRNA和DNA疫苗是GU癌症治疗的有希望的,快速发展的策略.
- 免疫基因组学和人工智能的整合可以提高疫苗设计的精度.
- 需要进一步的研究来克服瘤免疫逃避和监管障碍等挑战.
相关概念视频
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K


